Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Frailty 10Neoplasms 7Lymphoma 5Breast Neoplasms 4Prostatic Neoplasms 3Lung Neoplasms 3Lymphoma, Large B-Cell, Diffuse 2Colorectal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Urogenital Neoplasms 1Treatment Adherence and Compliance 1Stomach Neoplasms 1Solid Neoplasm 1Sarcopenia 1Sarcoma 1Recurrence 1Prostate Cancer Cured 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neoplasms, Plasma Cell 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphoma, B-Cell 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1Leukemia, Myeloid, Acute 1Kidney Neoplasms 1Hepatic Malignancies 1

Interventions

beta-Aminoethyl Isothiourea 1Weights and Measures 1Therapeutics 1Geriatric Assessment 1Cognitive Restructuring 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Treatment Adherence and Compliance × Geriatric Assessment × Clear all
NCT06373471 2024-04-18

IMPROVE

Odense University Hospital

Phase NA Recruiting
152 enrolled
Other hematologic neoplasm

Frailty, Treatment Adherence and Compliance, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡